In the year 2000, an estimated 17 million community-dwelling adults in the United States
had daily urinary incontinence (UI), and an additional 33 million suffered from the …

The impact of incontinence is felt by millions of people worldwide, with tremendous
decrement in quality of life and enormous cost reaching billions of dollars. Urinary …

Overactive bladder syndrome with and without urinary incontinence and related conditions,
signs, and disorders such as detrusor overactivity, neurogenic lower urinary tract …

In response to the growing population of older patients with incontinence, pharmaceutical
companies are developing new drugs to treat the condition. Before prescribing medications …

Urinary incontinence (UI) in older adults responds to a wide array of management strategies.
Best practice involves a stepped strategy moving from least invasive to more invasive …

Pharmacological management of urinary incontinence (UI) is currently based on
antimuscarinic and beta-3-agonist drugs. Botulinum toxin A detrusor injections represent an …

Urinary incontinence (UI) is a common, yet underdetected and under-reported, health
problem that can significantly affect quality of life. UI may also have serious medical and …

Accepted for publication January 23, 2012. cerebrovascular disease, diabetes,
hypertension, obstructive sleep apnea, and normal-pressure hydrocephalus. Functional …

In its broadest sense, urinary incontinence (UI) is defined as involuntary loss of urine to such
an extent as to become a hygienic or social concern to the patient [1]. Up to 50% of patients …

Loss of urinary control is closely linked with loss of independence. Most cases of urinary
incontinence can be improved using behavioral and pharmacologic interventions. Several …